Cytori Therapeutics, Inc. (CYTX) Reports In-Line Q1 Loss of 16c/Share

May 9, 2012 4:41 PM EDT
Cytori Therapeutics, Inc. (NASDAQ: CYTX) reported Q1 EPS of ($0.16), in-line with the analyst estimate of ($0.16). Revenue for the quarter came in at $1.48 million, versus $1.36 million reported last year.

For earnings history and earnings-related data on Cytori Therapeutics, Inc. (CYTX) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment